Ljósmæðrablaðið - 15.04.2002, Blaðsíða 33

tengjast beint við starfsemi betafruma í
brisi í fósturlífi. Þá er talið að óeðlileg
umbrotsefni frá móður geti haft áhrif á
þroskun taugakerfis en það virðist vera
minni háttar ef sykurstjórnun er þokkaleg
og barnið fær eðlilega örvun. Mæður
þessara barna þurfa að vera meðvitaðar
um þessi tengsl svo þær geti alið barnið
upp við góðar matarvenjur og reglulega
hreyfingu. Brjóstagjöf minnkar líkur á
offitu barns síðar á ævinni og mögulega
i?nnig líkur á að barnið fái sykursýki (40).
Framtíðin
t mæðravernd á Islandi þarf að taka
ákvörðun um skipulag skimunar fyrir
meðgöngusykursýki. Mikilvægt er að efla
næringarráðgjöf til allra þungaðra kvenna
og fræða konur um gildi hreyfingar og
mikilvægi þess að halda kjörþyngd til að
halda góðri heilsu í framtíðinni.
Þakkir
Reynir Tómas Geirsson og Astráður B.
Hreiðarsson fá sérstakar þakkir fyrir lestur
handrits og góðar ábendingar.
Heimildaskrá
1. Hreiðarsson ÁB, Geirsson RT, Helgason T. Diab Nutr
Metab 1993;6:333-4.
2. Vilbergsson S, Sigurðsson G, Sigvaldason H,
Hreiðarsson Áb, Sigfússon N. Prevalence and incidence
of NIDDM in Iceland: Evidence for Stable Incidence
Among Males and Females 1967-1991. The Reykjavík
Study. Diabetic Medicine 1997;14:491-98.
3. Hreiðarsson ÁB. Centralized Care Takes Effect in
Iceland. Diabetes Voice. 1999;44:17-18.
4. Heilbrigðis og tryggingamálaráðuneytið, Eggert
Sigfússon.Birt í Mbl. 29.7.2001.
5. Casson I, Clarke C, Howard C, et.al. Outcomes of
pregnancy in insulin dependent diabetic women: results
of a 5 year population cohort study. BMJ 1997:315:275-
78.
6. O'Sullivan JB. Diabetes Mellitus after GDM. Diabetes
40:131,1991.
7. O’Rahilly, Spivey RS, Holman RR, et. al. Type II
diabetes of early onset: a distinct clinical and genetic
syndrome? Br Med J 1987; 294:923.
8. Kristinsson SY, Þórólfsdóttir ET, Talseth B, et.al.
MODY in Ieland is associated with mutationsa in HNF-
alfa and a novel mutation in NeuroDl. Diabetologica
2001:44:2098-2103.
9. Moore T, Diabetes in Pregnancy . In: Creasy RK,
Resnik R (eds). Maternal Fetal Medicine, Principles and
Practice, WB Saunders Company, 1994, p.934-978.
10. Vadheim CM, Rotter JI, Maclaren NK, et. al.
Preferential transmission of diabetic alleles within the
HLA gene complex. N Engl J Med 1986:315:1314.
11. Yen SSC. Metabolic homeostasis during pregnancy.
In Yen SSC, Jaffe RF (eds). Reproductive Endocrinology.
Philadelphia, WB Saunders Company 1978.
12. Phelps RL, Metzger BE, Freinkel N. Carbohydrate
metabolism in pregnancy, XVIII: Diurnal profiles of
plamsa glucose, insulin, free fatty acids, triglycerides,
cholesterol and indivudial amino acids in late normal
pregnancy. Am J Obstet Gynecol 140:730, 1981
13. Freinkel N. Effects of the conceptus on maternal
metabolism during pregnancy. In: Leibel BS, Wrensall
GA (eds). On the nature and Treatment of Diabetes.
Amsterdam, Excerpta Medica, 1964.
14. American Diabetes Association. Principles of nutrition
and dietary recommendations for individuals with diabetes
mellitus. Diabetes Care 1979:2:520.
15. Reece EA. The history of diabetes mellitus. In: Reece
EA, Coustan DR, eds. Diabetes Mellitus in pregnancy,
principles and practice. Edinburgh, Churchill-Livingstone,
1988:10.
16. Reynir Tómas Geirsson. Meðganga hjá konum með
sykursýki; yfirlit um sykursýki í meðgöngu á íslandi
1981-1990. Ljósmæðrablaðið 1992;70:21-28.
17. Diamond MP, Shah DM, Hester RA, et.al.
Complications of insulin-dependent diabetic pregnancies
by preeclampsia and/or chronic hypertension: analysis
of outcome. Am J Perinatol 1985;2:263.
18. Ylinen K, Aula P, Stenman Y-H, Kesaniemi-Kokkanen
T, Teramo K. Risk of minor and major fetal malformations
in diabetics with high hemoglobin Alc values in early
pregnancy. Br Med J 1984:289:345.
19. Miiler E, Hare JW, Cloherty JP, et. ai. Elevated
maternal hemoglobin Alc in early pregnancy and major
congenital anomalies in infants of diabetic mothers. N
Engl J Med 1981:304:1331.
20. Hawthorne G, Robson S, Ryall E, et.al. Prospective
population based survey of outcome of pregnancy in
diabetic women: results of the Northern Diabetic
Pregnancy Audit, 1994. BMJ 1997;315:279-81.
21. Fuhrmann K, Risker H, Semmler K, et.al. Prevention
of congenital malformations in infant of insuiin-dependent
diabetic mothers. Diabetes Care 1983,6:219.
22. Hawthorne G, Irgens L Lie R. Outcome of pregnancy
in diabetic women in northeast England and in Norway,
1994-7. BMJ 2000;321:730-31.
23. Centers for Disease Control. Recommendations for
the use of folic acid to reduce the number of cases of
spina bifida and other neural tube defects. MMWR
1992;41 (RR-14): 1 -7 (Level III).
24. Centers for Disease Control. Use of folic acid for
prevention of spina bifida and other neural tube defects-
1983-1991. MMWR 1991;40:513-16 (level III).
25. Elliot JP, Garite TJ, Freeman RK, et.al. Ultrasonic
prediction of fetal macrosomia in diabetic patients. Obstet
Gynecol 1982:60:159.
26. Pedersen J. The pregnant diabetic and her newborn.
2nd ed. Copenhagen, Munksgaard, 1977.
27. Acker D, Sachs BP, Friedman EA. Risk factors for
shouider dystocia. Obstet Gynecol 1985:66:762.
28. Gilbert WM. Disorders of amniotic fluid. In: Creasy
RK, Resnik R (eds). Maternal Fetal Medicine, Principles
and Practice, WB Saunders Company, 1994, p.622.
29. Geirsson RT, Pálsson G, Bjarnadóttir RI, Garðarsdóttir
G. Skýrsla um burðarmálsdauða 1999, Landspítalinn,
Reykjavík, 2000.
30. Maresh M. Diabetes in pregnancy. Current Opin
Obstet Gynecol 13:103-107
31. Mölsted-Pedersen L. Management of pregnant
diabetics. Nord Med 1997;112:198-201
32. Kjos S, Walther FJ, Montoro M, et.al. Prevalence and
etiology of respiratory distress in infants of diabetic
mothers: predictive value of fetal lung maturation tests.
Am J Obsyet Gynecol 163:898, 1990
33. Moore T. Diabetes in Pregnancy. In: Creasy RK,
Resnik R (eds). Maternal Fetal Medicine, Principles and
Practice, WB Saunders Company, 1994, p.954.
34. Moore T. Diabetes in Pregnancy. In: Creasy RK,
Resnik R (eds). Maternal Fetai Medicine, Principles and